Tim Taps is the Senior Director of Regulatory Affairs, Head of Regulatory Strategy and Operations for Century Therapeutics, a US-based biotechnology company developing iPSC-derived NK and T cell therapies for both hematological and solid tumor malignancies. Tim’s 10 years of regulatory affairs experience also includes work on autologous CAR T cells, drug-device combinations, and complex generics. His interest in the parent/child IND concept began in 2019 and he has been active in internal and external discussion on the subject since.